Delivery Order SPE2DB20D3103-SPE2DB25FL6F5
Award Date
11/13/24
Potential Completion Date
11/14/24
Potential Value
$62K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $10,574.38, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, with a completion date of April 15, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it was not set aside for any specific business category. AmerisourceBergen Drug Corp holds...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,178.62 firm fixed-price delivery order is for the supply of GEMTESA 75 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of November 1, 2023 and was awarded on October 31, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $6,251.59, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, with a completion date of January 27, 2025. The contract has a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This federal contract award, valued at $78,816.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, with an ultimate completion date of April 9, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it was not designated as a Set-Aside contract. AmerisourceBergen Drug Corp holds a...
This federal contract award, valued at $2,419.17, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, with a performance period ending on January 17, 2024. The contract is structured as a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award, valued at $15,239.60, was granted by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the provision of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The contract has an Ultimate Completion Date of November 1, 2024 and a Firm Fixed Price pricing structure. This award is not associated with a set-aside designation, indicating open...
This federal contract award, valued at $19,547.91, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, with a completion date of June 25, 2024. The contract type is a Delivery Order, with a Firm Fixed Price pricing mechanism. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, on August 23, 2024. The $21,096.96 firm fixed-price delivery order is for the supply of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of August 26, 2024, and there is no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical...
This federal contract award, valued at $8,596.67, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GEMTESA 75 MG TABLET 30S, a pharmaceutical product, with a completion date of April 1, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation. AmerisourceBergen Drug Corp holds a significant...
This federal contract award, valued at $2,874.13, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, with an ultimate completion date of April 21, 2025. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This award is not associated with a set-aside designation, indicating open...